melatonin has been researched along with paclitaxel in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Colvin, L; Galley, HF; Lowes, DA; McCormick, B; Torsney, C; Wilson, KL | 1 |
| Chen, D; Du, J; Jiang, X; Li, X; Liang, Y; Liu, X; Ma, W; Wang, Q | 1 |
| Jung, JH; Kim, SH; Lee, H; Lee, HJ; Shin, EA | 1 |
| El-Sokkary, GH; Ismail, IA; Saber, SH | 1 |
| Blask, DE; Dauchy, RT; Frasch, T; Hill, SM; Hoffman, AE; Pointer, D; Xiang, S | 1 |
| Li, N; Liu, F; Liu, X; Song, Z; Teng, Z; Wang, Z; Zhang, Y; Zhu, P | 1 |
| Abdelhamid, FM; Aboelwafa, HR; El-Kott, AF; Ramadan, RA | 1 |
| Al Hassadi, Y; Aru, B; Erdogan, CS; Gemici, B; Yılmaz, B | 1 |
13 other study(ies) available for melatonin and paclitaxel
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the rat.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Cell Line, Tumor; Female; Humans; Hyperalgesia; Male; Melatonin; Mitochondria; Neuralgia; Paclitaxel; Rats; Rats, Sprague-Dawley | 2017 |
NQO2 inhibition relieves reactive oxygen species effects on mouse oocyte meiotic maturation and embryo development.
Topics: Animals; Antifibrinolytic Agents; Beclin-1; Embryo, Mammalian; Gene Expression Regulation, Enzymologic; Malondialdehyde; Meiosis; Melatonin; Mice; Nocodazole; Oocytes; Paclitaxel; Parthenogenesis; Protein Transport; Pyridines; Pyrrolizidine Alkaloids; Quinone Reductases; Reactive Oxygen Species; Tubulin Modulators; Vitamin K 3 | 2017 |
Melatonin disturbs SUMOylation-mediated crosstalk between c-Myc and nestin via MT1 activation and promotes the sensitivity of paclitaxel in brain cancer stem cells.
Topics: A549 Cells; Brain Neoplasms; HEK293 Cells; Hep G2 Cells; Humans; Matrix Metalloproteinase 14; Melatonin; Neoplastic Stem Cells; Nestin; Paclitaxel; Proto-Oncogene Proteins c-myc; Sumoylation | 2018 |
Melatonin inhibits breast cancer cell invasion through modulating DJ-1/KLF17/ID-1 signaling pathway.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cadherins; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; Inhibitor of Differentiation Protein 1; MCF-7 Cells; Melatonin; Neoplasm Invasiveness; Neoplasm Metastasis; Paclitaxel; Protein Deglycase DJ-1; Signal Transduction; Transcription Factors | 2019 |
Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.
Topics: Animals; Breast Neoplasms; Circadian Rhythm; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Melatonin; Paclitaxel; Rats, Nude; rho GTP-Binding Proteins; STAT3 Transcription Factor; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2019 |
Melatonin ameliorates paclitaxel-induced mice spermatogenesis and fertility defects.
Topics: Animals; Fertility; Male; Melatonin; Mice; Paclitaxel; Sperm Motility; Spermatogenesis; Spermatozoa; Testis | 2022 |
The protective effect of melatonin supplementation against taxol-induced testicular cytotoxicity in adult rats.
Topics: Animals; Apoptosis; Dietary Supplements; Male; Melatonin; Paclitaxel; Rats; Testis | 2022 |
Combinatorial effects of melatonin and paclitaxel differ depending on the treatment scheme in colorectal cancer in vitro.
Topics: Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Humans; Melatonin; Paclitaxel; TOR Serine-Threonine Kinases | 2022 |